SBIO
SBIO
About ALPS Medical Breakthroughs ETF
The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).
About ALPS Medical Breakthroughs ETF
The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 ALKS | Alkermes plc | 4.48% | 171.72K | $7.24M |
 KYMR | Kymera Therapeutics, Inc. | 4.23% | 84.15K | $6.85M |
 CELC | Celcuity Inc. | 3.92% | 47.69K | $6.34M |
 MIRM | Mirum Pharmaceuticals, Inc. | 3.90% | 62.20K | $6.31M |
 SYRE | Spyre Therapeutics, Inc. | 3.68% | 80.96K | $5.95M |
 CGON | CG Oncology, Inc. Common stock | 3.35% | 87.03K | $5.42M |
 APGE | Apogee Therapeutics, Inc. | 2.93% | 57.72K | $4.74M |
 XENE | Xenon Pharmaceuticals Inc. | 2.90% | 85.75K | $4.69M |
 TVTX | Travere Therapeutics, Inc. | 2.77% | 95.05K | $4.48M |
 DNTH | Dianthus Therapeutics, Inc. | 2.64% | 45.84K | $4.26M |
 NAMS | NewAmsterdam Pharma Company N.V. | 2.47% | 118.51K | $3.99M |
 VKTX | Viking Therapeutics, Inc. | 2.41% | 119.11K | $3.90M |
 CRNX | Crinetics Pharmaceuticals, Inc. | 2.37% | 107.89K | $3.84M |
 ACAD | ACADIA Pharmaceuticals Inc. | 2.35% | 175.74K | $3.81M |
 EWTX | Edgewise Therapeutics, Inc. | 2.33% | 110.58K | $3.78M |
 DNLI | Denali Therapeutics Inc. | 2.13% | 163.47K | $3.44M |
 ORKA | Oruka Therapeutics, Inc. | 1.81% | 49.90K | $2.92M |
 GPCR | Structure Therapeutics Inc. | 1.78% | 73.02K | $2.87M |
 IRON | Disc Medicine, Inc. | 1.69% | 39.33K | $2.74M |
 IDYA | IDEAYA Biosciences, Inc. | 1.65% | 90.52K | $2.67M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Ireland
Netherlands
Canada
Switzerland
China
Belgium
United Kingdom
GermanySECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Ireland Netherlands Canada Switzerland China Belgium United Kingdom GermanyHoldings (Top 20)
ALKS
Alkermes plc
KYMR
Kymera Therapeutics, Inc.
CELC
Celcuity Inc.
MIRM
Mirum Pharmaceuticals, Inc.
SYRE
Spyre Therapeutics, Inc.
CGON
CG Oncology, Inc. Common stock
APGE
Apogee Therapeutics, Inc.
XENE
Xenon Pharmaceuticals Inc.
TVTX
Travere Therapeutics, Inc.
DNTH
Dianthus Therapeutics, Inc.
NAMS
NewAmsterdam Pharma Company N.V.
VKTX
Viking Therapeutics, Inc.
CRNX
Crinetics Pharmaceuticals, Inc.
ACAD
ACADIA Pharmaceuticals Inc.
EWTX
Edgewise Therapeutics, Inc.
DNLI
Denali Therapeutics Inc.
ORKA
Oruka Therapeutics, Inc.
GPCR
Structure Therapeutics Inc.
IRON
Disc Medicine, Inc.
IDYA
IDEAYA Biosciences, Inc.